C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/04 (2006.01) A61K 31/70 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2196070
Antisense oligonucleotides that hybridize to segments of the preS1, S, C, and epsilon regions of the hepatitis B virus (HBV) RNA pregenome inhibit replication of the virus. The figure illustrates the relative positions of antisense oligonucleotides targeted against the HBV S gene. Pharmaceutical compositions which contain these oligonucleotides as the active ingredients are effective against HBV infection.
Des oligonucléotides antisens s'hybridant à des segments des régions preS1, S, C et epsilon du prégénome de l'ARN du virus de l'hépatite B (HBV) inhibent la réplication de ce virus. La figure illustre les positions relatives d'oligonucléotides antisens ciblés contre le gène S de HBV. Des compositions pharmaceutiques contenant ces oligonucléotides en tant qu'ingrédients actifs sont efficaces contre l'infection par HBV.
Gerin John L.
Korba Brent E.
Georgetown University
Smart & Biggar
LandOfFree
Antisense oligonucleotides against hepatitis b viral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides against hepatitis b viral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides against hepatitis b viral... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1436519